These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 22420469

  • 1. The relationship between performances on neuropsychological symptom validity testing and the MCMI-III in patients with fibromyalgia.
    Brooks L, Johnson-Greene D, Lattie E, Ference T.
    Clin Neuropsychol; 2012; 26(5):816-31. PubMed ID: 22420469
    [Abstract] [Full Text] [Related]

  • 2. Distinguishing between neuropsychological malingering and exaggerated psychiatric symptoms in a neuropsychological setting.
    Ruocco AC, Swirsky-Sacchetti T, Chute DL, Mandel S, Platek SM, Zillmer EA.
    Clin Neuropsychol; 2008 May; 22(3):547-64. PubMed ID: 17853126
    [Abstract] [Full Text] [Related]

  • 3. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A, Ingram MV, Ben-Porath YS.
    Clin Neuropsychol; 2012 May; 26(5):790-815. PubMed ID: 22709365
    [Abstract] [Full Text] [Related]

  • 4. Relationship between performance validity testing, disability status, and somatic complaints in patients with fibromyalgia.
    Johnson-Greene D, Brooks L, Ference T.
    Clin Neuropsychol; 2013 May; 27(1):148-58. PubMed ID: 23121595
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO, Wygant DB, Sellbom M, Ben-Porath YS.
    J Pers Assess; 2011 May; 93(5):508-17. PubMed ID: 21859291
    [Abstract] [Full Text] [Related]

  • 7. On the limits of effort testing: symptom validity tests and severity of neurocognitive symptoms in nonlitigant patients.
    Merten T, Bossink L, Schmand B.
    J Clin Exp Neuropsychol; 2007 Apr; 29(3):308-18. PubMed ID: 17454351
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non-psychotic psychiatric populations.
    Schroeder RW, Marshall PS.
    Clin Neuropsychol; 2011 Apr; 25(3):437-53. PubMed ID: 21391153
    [Abstract] [Full Text] [Related]

  • 9. Intact cognitive inhibition in patients with fibromyalgia but evidence of declined processing speed.
    Veldhuijzen DS, Sondaal SF, Oosterman JM.
    J Pain; 2012 May; 13(5):507-15. PubMed ID: 22564673
    [Abstract] [Full Text] [Related]

  • 10. Let's not get hysterical: comparing the MMPI-2 validity, clinical, and RC scales in TBI litigants tested for effort.
    Thomas ML, Youngjohn JR.
    Clin Neuropsychol; 2009 Aug; 23(6):1067-84. PubMed ID: 19343593
    [Abstract] [Full Text] [Related]

  • 11. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB, Sellbom M, Ben-Porath YS, Stafford KP, Freeman DB, Heilbronner RL.
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [Abstract] [Full Text] [Related]

  • 12. The effect of failure on cognitive and psychological symptom validity tests in litigants with symptoms of post-traumatic stress disorder.
    Demakis GJ, Gervais RO, Rohling ML.
    Clin Neuropsychol; 2008 Sep; 22(5):879-95. PubMed ID: 18756390
    [Abstract] [Full Text] [Related]

  • 13. The latent structure of cognitive symptom exaggeration on the Victoria Symptom Validity Test.
    Frazier TW, Youngstrom EA, Naugle RI, Haggerty KA, Busch RM.
    Arch Clin Neuropsychol; 2007 Feb; 22(2):197-211. PubMed ID: 17276652
    [Abstract] [Full Text] [Related]

  • 14. Evaluation context and Symptom Validity Test performances in a U.S. Military sample.
    Armistead-Jehle P, Buican B.
    Arch Clin Neuropsychol; 2012 Dec; 27(8):828-39. PubMed ID: 23047953
    [Abstract] [Full Text] [Related]

  • 15. Performance validity and neuropsychological outcomes in litigants and disability claimants.
    Davis JJ, McHugh TS, Axelrod BN, Hanks RA.
    Clin Neuropsychol; 2012 Dec; 26(5):850-65. PubMed ID: 22630329
    [Abstract] [Full Text] [Related]

  • 16. MCMI-III diagnostic validity: bad test or bad validity study.
    Retzlaff P.
    J Pers Assess; 1996 Apr; 66(2):431-7. PubMed ID: 8869582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Classification accuracy of the Millon Clinical Multiaxial Inventory-III modifier indices in the detection of malingering in traumatic brain injury.
    Aguerrevere LE, Greve KW, Bianchini KJ, Ord JS.
    J Clin Exp Neuropsychol; 2011 Jun; 33(5):497-504. PubMed ID: 21424973
    [Abstract] [Full Text] [Related]

  • 19. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 20. Test of Memory Malingering (TOMM) scores are not affected by chronic pain or depression in patients with fibromyalgia.
    Iverson GL, Le Page J, Koehler BE, Shojania K, Badii M.
    Clin Neuropsychol; 2007 May; 21(3):532-46. PubMed ID: 17455036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.